Showing results (51-60 of 62) with videos related to
Sort By:
Pageof 7
Journal of Clinical Neurophysiology : Official Publication of the American Electroencephalographic Society|October 2, 2014
Duration of the distal compound muscle action potential for diagnosis of chronic inflammatory demyelinating polyneuropathy: effects of low-cut filtersSagiri Isose, Sonoko Misawa, Masahiro Sonoo, et al.Experimental Neurology|September 13, 2011
Markedly reduced axonal potassium channel expression in human sporadic amyotrophic lateral sclerosis: an immunohistochemical studyKazumoto Shibuya, Sonoko Misawa, Kimihito Arai, et al.Amyotrophic Lateral Sclerosis : Official Publication of the World Federation of Neurology Research Group on Motor Neuron Diseases|December 4, 2010
Elevated CSF TDP-43 levels in amyotrophic lateral sclerosis: specificity, sensitivity, and a possible prognostic valueYu-Ichi Noto, Kazumoto Shibuya, Yasunori Sato, et al.Neurology|June 13, 2014
Moesin is a possible target molecule for cytomegalovirus-related Guillain-Barré syndromeSetsu Sawai, Mamoru Satoh, Masahiro Mori, et al.Neurology|July 31, 2012
Markedly upregulated serum interleukin-12 as a novel biomarker in POEMS syndromeKazuaki Kanai, Setsu Sawai, Kazuyuki Sogawa, et al.Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|May 12, 2015
A single blind randomized controlled clinical trial of mexiletine in amyotrophic lateral sclerosis: Efficacy and safety of sodium channel blocker phase II trialKazumoto Shibuya, Sonoko Misawa, Hideki Kimura, et al.Journal of Neurology, Neurosurgery, and Psychiatry|April 9, 2018
Altered cerebral blood flow in the anterior cingulate cortex is associated with neuropathic painKeisuke Watanabe, Shigeki Hirano, Kazuho Kojima, et al.Neurology|May 30, 2020
Homozygous nonsense variant in LRIF1 associated with facioscapulohumeral muscular dystrophyKohei Hamanaka, Darina Šikrová, Satomi Mitsuhashi, et al.The Lancet. Neurology|August 7, 2016
Safety and efficacy of thalidomide in patients with POEMS syndrome: a multicentre, randomised, double-blind, placebo-controlled trialSonoko Misawa, Yasunori Sato, Kanako Katayama, et al.JMIR Research Protocols|November 9, 2016
A Prospective, Multicenter, Randomized Phase II Study to Evaluate the Efficacy and Safety of Eculizumab in Patients with Guillain-Barré Syndrome (GBS): Protocol of Japanese Eculizumab Trial for GBS (JET-GBS)Nobuko Yamaguchi, Sonoko Misawa, Yasunori Sato, et al.Pageof 7